SunBio,Inc. (KOSDAQ:067370)

Market Cap	69.14B
Revenue (ttm)	2.17B +2.3%
Net Income	1.39B
EPS	249.33
Shares Out	12.19M
PE Ratio	22.74
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,994
Average Volume	18,236
Open	5,670.00
Previous Close	5,670.00
Day's Range	5,460.00 - 5,670.00
52-Week Range	5,010.00 - 10,170.00
Beta	0.43
RSI	46.47
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1997
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 067370